Registry of Lobbyists
| Subject matters | Details | Categories |
|---|---|---|
|
Budget, Health
|
Advocacy to maintain and increase funding for the National Immunization Strategy and discussions on vaccine procurement.
|
Grant, Contribution or Other Financial Benefit, Policies or Program
|
|
Health, International Trade
|
Consider amendments to the Food and Drugs Act, or the Export and Imports Permits Act (Export Control List) or any other legislative and regulatory means in order to protect the Canadian supply of drugs in light of potential importation legislation in the United States.
|
Regulation, Policies or Program, Legislative Proposal, Bill or Resolution
|
|
Health, Intellectual Property, International Trade
|
Discussions around the World Trade Organization consideration of a TRIPS Patent Waiver and the World Health Organization pandemic treaty proposal
|
Regulation, Policies or Program, Legislative Proposal, Bill or Resolution
|
|
Government Procurement, Health
|
Discussions on the procurement of a COVID19 vaccine and therapy
|
Grant, Contribution or Other Financial Benefit
|
|
Health, Industry
|
Engage the Federal Government on Health Canada’s Regulatory Innovation Agenda (Agile Licensing Modernization) to discuss opportunities for further harmonization; flexibility and predictability in the new regulatory framework being develop and its linkage to pillar 5 of the Biomanufacturing and Life Sciences Strategy.
|
Policies or Program, Regulation
|
|
Government Procurement, Health
|
Federal Public Drug Plans, with respect to the reimbursement of therapeutic products for Federal plan beneficiaries
|
Policies or Program
|
|
Health
|
Health Canada’s policies, program and guidelines related to the management, prevention, mitigation and notification of drug shortages
|
Policies or Program, Regulation, Legislative Proposal, Bill or Resolution
|
|
Health
|
Monitoring and engaging on the Government’s commitment to create a national strategy for rare diseases; the Canadian Drug Agency; and C64, An Act to Implement pharmacare.
|
Policies or Program, Regulation, Legislative Proposal, Bill or Resolution
|
|
Health, Industry, International Trade
|
Monitoring and engaging the Government and Parliamentarians on policies and programs related to Canada's life sciences & biomanufacturing strategy
|
Policies or Program, Regulation
|
|
Government Procurement
|
Monitoring and engaging the Government and Parliamentarians on the House of Commons Standing Committee on Public Accounts (PACP) motion related to the discloser on vaccine contracts
|
Legislative Proposal, Bill or Resolution
|
|
Health
|
Patented Medicine Prices Review Board (PMPRB) amendments to the Patented Medicines Regulations and the related proposed guidelines.
|
Policies or Program, Regulation
|
|
Health
|
Regulations, policies and programs related to the reimbursement recommendations decision-making process and framework done by the Canadian Drug Agency as well as the review times and processes conducted by Health Canada for the purpose of obtaining a notice of compliance.
|
Policies or Program, Regulation
|
|
Industry
|
The Department of Innovation, Science and Economic Development and the Innovation Agenda for the life sciences sector: policy or program initiatives to support life science research and development conducted in Canada and manufacturing capability.
|
Policies or Program
|
Pfizer's mission is to discover and develop innovative medicines, vaccines and other products to improve the quality of life of people and animals.
Najah Sampson, President
Address:
17,300 TRANS-CANADA HIGHWAY
KIRKLAND, QC H9J 2M5
Canada
Telephone number:
514-693-4264
Pfizer Canada ULC does not have any subsidiaries that could have a direct interest in the outcome of the undertaking